ASCPT appointment
This article was originally published in The Tan Sheet
Executive Summary
Bernard Schachtel, MD, Department of Epidemiology & Public Health, Yale University School of Medicine, has been appointed Vice Chair of the Drug Development & Regulatory (DDR) Science Section of the American Society for Clinical Pharmacology & Therapeutics. DDR is the largest section in the Society, with activities encompassing U.S. and worldwide governmental regulations as well as issues affecting the development of pharmaceuticals, nonprescription drugs, nutritional supplements and medical devices. Schachtel also serves as Medical Director of Schachtel Research Company, Jupiter, Fla...
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.